The relation between COL6A5 expression and malignancy is further supported by the fact that COL6A5 expression was not changing between normal stroma and benign canine mammary adenomas, but showed high expression in canine mammary carcinomas and correlates with worse overall survival in human breast cancer patients [13]. The gene discussed is COL6A5; the disease is breast cancer.